Literature DB >> 19712116

Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus.

V Schmitt1, A M Meuth, S Amler, E Kuehn, M Haust, G Messer, V Bekou, C Sauerland, D Metze, W Köpcke, G Bonsmann, A Kuhn.   

Abstract

Background Lupus erythematosus tumidus (LET) is a rare disease which was first described in 1909 but has not always been considered as a separate entity of cutaneous lupus erythematosus (CLE) in the international literature. Objectives To compare characteristic features of different subtypes of CLE and to analyse whether LET can be distinguished as a separate entity in the classification system of the disease. Methods The study involved 44 patients with CLE, including 24 patients with LET, 12 with discoid lupus erythematosus (DLE) and eight with subacute CLE (SCLE), from two centres in Germany. A core set questionnaire and an SPSS database were designed to enable a consistent statistical analysis. Results Location of skin lesions did not differ significantly between the CLE subtypes; however, the activity score was significantly lower in LET than in DLE (P < 0.01), and the damage score was significantly lower in LET than in SCLE (P < 0.01) and DLE (P < 0.01). Photosensitivity and antinuclear antibodies were confirmed to be different in LET compared with SCLE and DLE but without statistical significance. Moreover, histological analysis of skin biopsy specimens showed that abundant mucin deposition is significantly more present in LET compared with SCLE (P < 0.01) and DLE (P < 0.01) while prominent interface dermatitis and alteration of hair follicles were absent in LET. Conclusions Several significant differences were found between LET and other subtypes of CLE with regard to clinical, histological and laboratory parameters. These data strongly indicate that LET should be defined as a separate entity in the classification of CLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712116     DOI: 10.1111/j.1365-2133.2009.09401.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

1.  [Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus].

Authors:  M Sticherling
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

2.  Lupus erythematosus tumidus: a unique disease entity.

Authors:  Rodger Stitt; Colby Fernelius; Jefferson Roberts; Troy Denunzio; Navin S Arora
Journal:  Hawaii J Med Public Health       Date:  2014-09

3.  Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem.

Authors:  Ilko Bakardzhiev; Anastasiya Atanasova Chokoeva; Ivan Krasnaliev; Claudio Tana; Uwe Wollina; Torello Lotti; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2016-01-13

Review 4.  Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents.

Authors:  Camilla Dalle Vedove; Jan C Simon; Giampiero Girolomoni
Journal:  J Dtsch Dermatol Ges       Date:  2012-09-03       Impact factor: 5.584

Review 5.  Lupus erythematosus revisited.

Authors:  Annegret Kuhn; Joerg Wenzel; Marc Bijl
Journal:  Semin Immunopathol       Date:  2015-12-04       Impact factor: 11.759

Review 6.  Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review.

Authors:  Annegret Kuhn; Jörg Wenzel; Heiko Weyd
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 10.817

7.  Clinical characteristics of cutaneous lupus erythematosus.

Authors:  Justyna Szczęch; Maja Rutka; Dominik Samotij; Agnieszka Zalewska; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

8.  A case report of lupus erythematosus tumidus converted from discoid lupus erythematosus.

Authors:  Xiaomei Chen; Sheng Wang; Li Li
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

9.  Lupus erythematosus tumidus: clinical perspectives.

Authors:  Nikolaos Patsinakidis; Ocko Kautz; Bernhard F Gibbs; Ulrike Raap
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-10-01

10.  Tumid lupus erythematosus: an intriguing dermatopathological connotation treated successfully with topical tacrolimus and hydroxyxhloroquine combination.

Authors:  Prashant Verma; Sonal Sharma; Pravesh Yadav; Chaitanya Namdeo; Garima Mahajan
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.